lobbying_activities: 1146322
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1146322 | df45bb38-c683-42c7-acea-e5c0bcbd514e | Q3 | HOLLAND & KNIGHT LLP | 18466 | ALLIANCE FOR REGENERATIVE MEDICINE | 2011 | third_quarter | SCI | Advocate for funding for regenerative medicine companies; Advocate for NIH funding for regenerative medicine research. Advocate for new regulations re: approval of regenerative medicine products. Advocate for funding for the FDA. Work with NIST officials on standards for reginerative medicine products. Advocate for assessment of federal regenerative medicine activities. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE | 80000 | 0 | 0 | 2011-10-11T11:32:10.710000-04:00 |